课题基金 / 基金详情

Role of macrophages in organophosphorus pesticide-induced airway hyperreactivity

Role of macrophages in organophosphorus pesticide-induced airway hyperreactivity
巨噬细胞在有机磷农药引起的气道高反应性中的作用
批准号:
8663694
负责人:
ALLISON Deborah FRYER
金额:
$33.96万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-07 至 2015-04-30

项目摘要

项目成果

ALLISON Deborah FRYER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We have demonstrated that in a guinea pig model, organophosphorus pesticides (OPs) cause airway hyperreactivity that is dose-related and associated with the functional loss of autoinhibitory muscarinic M2 receptors that normally limit acetylcholine release from parasympathetic nerves that innervate airway smooth muscle. We recently reported that sensitization to antigen alters the mechanisms underlying OP-induced airway hyperreactivity to involve IL-5-dependent mechanisms in the sensitized but not the non-sensitized guinea pig. How OPs cause neuronal M2 dysfunction in the non-sensitized animal is not known but our preliminary data indicate that this effect is not mediated by cholinesterase inhibition or direct antagonistic interactions with neuronal M2 receptors. Rather, OPs appear to influence neuronal M2 receptor function indirectly via effects on macrophages since depletion of macrophages using liposome-encapsulated clodronate protects against OP-induced airway hyperreactivity. It is our hypothesis that OPs activate macrophages to upregulate expression and release of inflammatory cytokines previously shown to cause M2 receptor dysfunction in various models of airway hyperreactivity. We propose four Aims to test this hypothesis. In Aim 1, we will use in vivo physiological measurements to confirm that macrophages mediate airway hyperreactivity caused by OPs and determine whether their role changes over time, as has been observed for eosinophils in ozone-induced airway hyperreactivity. Aim 2 will utilize macrophages isolated from bronchoalveolar lavage collected from OP-treated versus untreated guinea pigs guinea pigs to examine the effect of OPs on macrophage expression and release of inflammatory cytokines implicated in airway hyperreactivity. In Aim 3, we will use primary nerve cell cultures to determine whether OP- induced macrophage mediators interact with nerves directly to alter M2 receptor expression or function or the structural plasticity of nerves. Aim 4 will confirm the in vivo physiological relevance of OP-induced macrophage mediators identified in aims 2 and 3. Mechanistic studies are critical to developing preventive and therapeutic approaches for OP-induced airway hyperreactivity, which are likely to differ between sensitized (allergic) and non-sensitized individuals, and for determining the risks to human health posed by OP exposures. The public health implications of these studies are significant in light of the increasing prevalence of asthma, the wide spread exposure of humans and especially children to OPs and the credible threat of terrorist use of OP pesticides and nerve agents.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Pioglitazone prevents obesity-related airway hyperreactivity and neuronal M2 receptor dysfunction.
吡格列酮可预防肥胖相关的气道高反应性和神经元 M2 受体功能障碍。
DOI: 10.1152/ajplung.00567.2020
发表时间: 2021
期刊: American journal of physiology. Lung cellular and molecular physiology
影响因子: --
作者: [Proskocil,BeckyJ, Fryer,AllisonD, Jacoby,DavidB, Nie,Zhenying]
通讯作者: Nie,Zhenying
DOI: 10.1371/journal.pone.0054926
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者: [Grodzki AC, Giulivi C, Lein PJ]
通讯作者: Lein PJ
Insulin increases nerve-mediated bronchoconstriction in obesity-related asthma
  • 批准号:
    10587344
  • 项目类别:
  • 资助金额:
    $63.05万
  • 财政年份:
    2022
  • 负责人:
    ALLISON Deborah FRYER
  • 依托单位:
Oregon Clinical and Translational Research Institute TL1 Program
  • 批准号:
    9514380
  • 项目类别:
  • 资助金额:
    $52.04万
  • 财政年份:
    2017
  • 负责人:
    ALLISON Deborah FRYER
  • 依托单位:
NRSA Training Core
  • 批准号:
    10693309
  • 项目类别:
  • 资助金额:
    $81.83万
  • 财政年份:
    2017
  • 负责人:
    ALLISON Deborah FRYER
  • 依托单位:
Oregon Clinical and Translational Research Institute TL1 Program
  • 批准号:
    10197247
  • 项目类别:
  • 资助金额:
    $62.93万
  • 财政年份:
    2017
  • 负责人:
    ALLISON Deborah FRYER
  • 依托单位:
海外基金